NEW YORK ─ Swedish startup Capitainer on Tuesday announced that it has closed on SEK 31 million ($3.7 million) in financing to roll out its qDBS dried-blood-spot testing system.
Stockholm-based Capitainer said the investment comes as it anticipates an increase in demand for dried blood spot sampling for antibody testing to confirm COVID-19 vaccine efficacy. It will use the funds to ramp up production capacity and build a European sales and marketing network.